Oct 31, 2025 11:51 AM Eastern Daylight Time Industry: Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference Share BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the 2nd Annual Guggenheim Healthcare Innovation Conference on Tuesday, Nov. 11, 2025 at 8:30 a.m. ET. About Immunome, Inc. Immunome is a clinical-s ...